Unitedhealth Group Inc
UNH352.510USD
Today
-0.30%
5 Days
+11.77%
1 Month
+29.69%
6 Months
-26.79%
Year to Date
-30.31%
1 Year
-40.69%
TradingKey Stock Score
Currency: USD Updated：2025-09-12Key Insights
The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a very weak stock market performance, the company shows strong technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
Score Analysis
Analyst Rating
Company Highlights
UnitedHealth Group Incorporated is an American multinational for-profit organization that specializes in health insurance and healthcare services, located in Eden Prairie, Minnesota. Operating under the UnitedHealthcare brand for insurance products and the Optum brand for healthcare services, it is recognized as the world's seventh-largest company by revenue and the largest healthcare corporation by revenue. The company ranks 8th on the 2024 Fortune Global 500 list, with a market capitalization of $460.3 billion as of December 20, 2024. UnitedHealth Group has encountered numerous investigations, lawsuits, and penalties—including SEC enforcement related to stock option backdating, Medicare overbilling, unfair claims practices, denials of mental health treatments, and anticompetitive conduct—illuminating deep-rooted issues of fraud, patient harm, and corporate misconduct.
News
Why UnitedHealth Stock Dipped Today After Bumping Higher Monday
Key PointsOne pundit tracking the stock became less bullish on its future.He knocked down his price target by 37%.10 stocks we like better than UnitedHealth Group › What the stock analysis community giveth, it can also taketh away.That was the dynamic behind the slide of UnitedHealth Group...
.jpg)
UnitedHealth Stock Jumps over 3% Premarket After a 12% Rally Last Friday
UnitedHealth stock jumped over 3% in premarket trading after a 12% rally last Friday, following regulatory filings that showed Warren Buffett’s Berkshire Hathaway and Michael Burry’s Scion Asset Management each made large new investments in the health insurer during the second quarter.
UnitedHealth jumps after Berkshire Hathaway buys new stake
Aug 15 (Reuters) - Shares of UnitedHealth Group UNH.N surged more than 12% in premarket trading on Friday after Warren Buffett's Berkshire Hathaway BRKa.N revealed a new investment in the health insurer.
Warren Buffett Q2 2025 13F Analysis: Betting on UnitedHealth Again After 14 Years
TradingKey - In Q2 2025, the value of Berkshire Hathaway’s investment portfolio declined from $259.8 billion in Q1 to $257.5 billion, a decrease of 0.89%. Analysis indicates that this drop is primarily driven by a net capital outflow of 0.78%. The outflow may be linked to changing market conditions
UnitedHealth’s Turnaround Story? Buffett and David Tepper Both “Buy the Dip” in Q2 on This Retail Favorite
TradingKey - A series of setbacks — executive turmoil, rising medical costs, and cyberattacks — have halved the stock price of UnitedHealth (UNH), the U.S. health insurance leader, in 2025. Yet Wall Street’s most legendary investors see a “buying opportunity”: In their Q2 13F filings, Berkshire
Berkshire invests in UnitedHealth, trims Apple stake
Aug 14 (Reuters) - Warren Buffett's Berkshire Hathaway BRKa.N disclosed on Thursday a new investment in UnitedHealth Group UNH.N after the insurer became a target for many Americans upset over the direction of the nation's healthcare.
Financial Indicators
EPS
Total revenue
Company
UnitedHealth Group Incorporated is an American multinational for-profit organization that specializes in health insurance and healthcare services, located in Eden Prairie, Minnesota. Operating under the UnitedHealthcare brand for insurance products and the Optum brand for healthcare services, it is recognized as the world's seventh-largest company by revenue and the largest healthcare corporation by revenue. The company ranks 8th on the 2024 Fortune Global 500 list, with a market capitalization of $460.3 billion as of December 20, 2024. UnitedHealth Group has encountered numerous investigations, lawsuits, and penalties—including SEC enforcement related to stock option backdating, Medicare overbilling, unfair claims practices, denials of mental health treatments, and anticompetitive conduct—illuminating deep-rooted issues of fraud, patient harm, and corporate misconduct.
